Drugs / NTCB02-1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06625957 | Dec 2024 → Jul 2025 overdue | — | Yuhan Corporation | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NTCB02-1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06625957 ↗ |